BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31396541)

  • 1. Immunopathology of Airway Surface Liquid Dehydration Disease.
    Lewis BW; Patial S; Saini Y
    J Immunol Res; 2019; 2019():2180409. PubMed ID: 31396541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNSP113 (PAAG) improves mucociliary transport and lung pathology in the Scnn1b-Tg murine model of CF lung disease.
    Harris ES; Novak L; Fernandez-Petty CM; Lindgren NR; Baker SM; Birket SE; Rowe SM
    J Cyst Fibros; 2023 Nov; 22(6):1104-1112. PubMed ID: 37714777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Spdef in the Regulation of Muc5b Expression in the Airways of Naive and Mucoobstructed Mice.
    Chen G; Volmer AS; Wilkinson KJ; Deng Y; Jones LC; Yu D; Bustamante-Marin XM; Burns KA; Grubb BR; O'Neal WK; Livraghi-Butrico A; Boucher RC
    Am J Respir Cell Mol Biol; 2018 Sep; 59(3):383-396. PubMed ID: 29579396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.
    Livraghi-Butrico A; Grubb BR; Wilkinson KJ; Volmer AS; Burns KA; Evans CM; O'Neal WK; Boucher RC
    Mucosal Immunol; 2017 Mar; 10(2):395-407. PubMed ID: 27435107
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Ion Transport to Restore Airway Hydration in Cystic Fibrosis.
    Reihill JA; Douglas LEJ; Martin SL
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33810137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Mall MA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal Pulmonary Macrophage Depletion Coupled to Defective Mucus Clearance Increases Susceptibility to Pneumonia and Alters Pulmonary Immune Responses.
    Saini Y; Wilkinson KJ; Terrell KA; Burns KA; Livraghi-Butrico A; Doerschuk CM; O'Neal WK; Boucher RC
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):210-21. PubMed ID: 26121027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.
    Gehrig S; Duerr J; Weitnauer M; Wagner CJ; Graeber SY; Schatterny J; Hirtz S; Belaaouaj A; Dalpke AH; Schultz C; Mall MA
    Am J Respir Crit Care Med; 2014 May; 189(9):1082-92. PubMed ID: 24678594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.
    Boucher RC
    Annu Rev Med; 2007; 58():157-70. PubMed ID: 17217330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Cftr function exacerbates the phenotype of Na(+) hyperabsorption in murine airways.
    Livraghi-Butrico A; Kelly EJ; Wilkinson KJ; Rogers TD; Gilmore RC; Harkema JR; Randell SH; Boucher RC; O'Neal WK; Grubb BR
    Am J Physiol Lung Cell Mol Physiol; 2013 Apr; 304(7):L469-80. PubMed ID: 23377346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
    Clunes MT; Boucher RC
    Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CFTR in airway disease.
    Pilewski JM; Frizzell RA
    Physiol Rev; 1999 Jan; 79(1 Suppl):S215-55. PubMed ID: 9922383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
    Moore PJ; Tarran R
    Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models.
    Mall MA
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):13-24. PubMed ID: 18518828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of IL-33 Suppresses
    Lewis BW; Vo T; Choudhary I; Kidder A; Bathula C; Ehre C; Wakamatsu N; Patial S; Saini Y
    J Immunol; 2020 Mar; 204(6):1650-1660. PubMed ID: 32060135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport.
    Scott DW; Walker MP; Sesma J; Wu B; Stuhlmiller TJ; Sabater JR; Abraham WM; Crowder TM; Christensen DJ; Tarran R
    Am J Respir Crit Care Med; 2017 Sep; 196(6):734-744. PubMed ID: 28481660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis.
    Shei RJ; Peabody JE; Kaza N; Rowe SM
    Curr Opin Pharmacol; 2018 Dec; 43():152-165. PubMed ID: 30340955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired mucus clearance exacerbates allergen-induced type 2 airway inflammation in juvenile mice.
    Fritzsching B; Hagner M; Dai L; Christochowitz S; Agrawal R; van Bodegom C; Schmidt S; Schatterny J; Hirtz S; Brown R; Goritzka M; Duerr J; Zhou-Suckow Z; Mall MA
    J Allergy Clin Immunol; 2017 Jul; 140(1):190-203.e5. PubMed ID: 27865862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.